nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiotepa—Alkylating Activity—Temozolomide—skin cancer	0.318	0.556	CiPCiCtD
Thiotepa—sarcoma—skin cancer	0.285	1	CtDrD
Thiotepa—Alkylating Activity—Dacarbazine—skin cancer	0.254	0.444	CiPCiCtD
Thiotepa—CYP3A4—Imiquimod—skin cancer	0.0244	0.292	CbGbCtD
Thiotepa—CYP3A4—Temozolomide—skin cancer	0.0244	0.292	CbGbCtD
Thiotepa—CYP3A4—Vismodegib—skin cancer	0.0169	0.202	CbGbCtD
Thiotepa—CYP3A4—Vemurafenib—skin cancer	0.0133	0.16	CbGbCtD
Thiotepa—CYP3A4—Docetaxel—skin cancer	0.00458	0.0548	CbGbCtD
Thiotepa—Alopecia—Bleomycin—skin cancer	8e-05	0.00136	CcSEcCtD
Thiotepa—Dyspepsia—Imiquimod—skin cancer	7.97e-05	0.00135	CcSEcCtD
Thiotepa—Pneumonia—Fluorouracil—skin cancer	7.88e-05	0.00134	CcSEcCtD
Thiotepa—Erythema—Bleomycin—skin cancer	7.88e-05	0.00134	CcSEcCtD
Thiotepa—Decreased appetite—Imiquimod—skin cancer	7.87e-05	0.00134	CcSEcCtD
Thiotepa—Infestation NOS—Fluorouracil—skin cancer	7.84e-05	0.00133	CcSEcCtD
Thiotepa—Infestation—Fluorouracil—skin cancer	7.84e-05	0.00133	CcSEcCtD
Thiotepa—Hypersensitivity—Vemurafenib—skin cancer	7.82e-05	0.00133	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Imiquimod—skin cancer	7.81e-05	0.00133	CcSEcCtD
Thiotepa—Fatigue—Imiquimod—skin cancer	7.8e-05	0.00133	CcSEcCtD
Thiotepa—Pain—Imiquimod—skin cancer	7.74e-05	0.00132	CcSEcCtD
Thiotepa—Haemoglobin—Temozolomide—skin cancer	7.67e-05	0.0013	CcSEcCtD
Thiotepa—Stomatitis—Fluorouracil—skin cancer	7.64e-05	0.0013	CcSEcCtD
Thiotepa—Haemorrhage—Temozolomide—skin cancer	7.63e-05	0.0013	CcSEcCtD
Thiotepa—Conjunctivitis—Fluorouracil—skin cancer	7.62e-05	0.0013	CcSEcCtD
Thiotepa—Asthenia—Vemurafenib—skin cancer	7.62e-05	0.0013	CcSEcCtD
Thiotepa—Hallucination—Temozolomide—skin cancer	7.6e-05	0.00129	CcSEcCtD
Thiotepa—Chills—Dactinomycin—skin cancer	7.57e-05	0.00129	CcSEcCtD
Thiotepa—Urinary tract disorder—Temozolomide—skin cancer	7.54e-05	0.00128	CcSEcCtD
Thiotepa—Cardiac failure—Docetaxel—skin cancer	7.52e-05	0.00128	CcSEcCtD
Thiotepa—Pruritus—Vemurafenib—skin cancer	7.51e-05	0.00128	CcSEcCtD
Thiotepa—Connective tissue disorder—Temozolomide—skin cancer	7.5e-05	0.00128	CcSEcCtD
Thiotepa—Urethral disorder—Temozolomide—skin cancer	7.48e-05	0.00127	CcSEcCtD
Thiotepa—Alopecia—Dactinomycin—skin cancer	7.46e-05	0.00127	CcSEcCtD
Thiotepa—Feeling abnormal—Imiquimod—skin cancer	7.46e-05	0.00127	CcSEcCtD
Thiotepa—Gastrointestinal pain—Imiquimod—skin cancer	7.4e-05	0.00126	CcSEcCtD
Thiotepa—Epistaxis—Fluorouracil—skin cancer	7.39e-05	0.00126	CcSEcCtD
Thiotepa—Erythema—Dactinomycin—skin cancer	7.35e-05	0.00125	CcSEcCtD
Thiotepa—Agranulocytosis—Fluorouracil—skin cancer	7.31e-05	0.00124	CcSEcCtD
Thiotepa—Anaemia—Bleomycin—skin cancer	7.28e-05	0.00124	CcSEcCtD
Thiotepa—Diarrhoea—Vemurafenib—skin cancer	7.26e-05	0.00123	CcSEcCtD
Thiotepa—Urticaria—Imiquimod—skin cancer	7.19e-05	0.00122	CcSEcCtD
Thiotepa—Body temperature increased—Imiquimod—skin cancer	7.16e-05	0.00122	CcSEcCtD
Thiotepa—Abdominal pain—Imiquimod—skin cancer	7.16e-05	0.00122	CcSEcCtD
Thiotepa—Eye disorder—Temozolomide—skin cancer	7.14e-05	0.00121	CcSEcCtD
Thiotepa—Tinnitus—Temozolomide—skin cancer	7.12e-05	0.00121	CcSEcCtD
Thiotepa—Cardiac disorder—Temozolomide—skin cancer	7.09e-05	0.00121	CcSEcCtD
Thiotepa—Haemoglobin—Fluorouracil—skin cancer	7.07e-05	0.0012	CcSEcCtD
Thiotepa—Leukopenia—Bleomycin—skin cancer	7.05e-05	0.0012	CcSEcCtD
Thiotepa—Haemorrhage—Fluorouracil—skin cancer	7.03e-05	0.0012	CcSEcCtD
Thiotepa—Dizziness—Vemurafenib—skin cancer	7.02e-05	0.00119	CcSEcCtD
Thiotepa—Angiopathy—Temozolomide—skin cancer	6.93e-05	0.00118	CcSEcCtD
Thiotepa—Ataxia—Docetaxel—skin cancer	6.9e-05	0.00117	CcSEcCtD
Thiotepa—Immune system disorder—Temozolomide—skin cancer	6.9e-05	0.00117	CcSEcCtD
Thiotepa—Mediastinal disorder—Temozolomide—skin cancer	6.88e-05	0.00117	CcSEcCtD
Thiotepa—Cough—Bleomycin—skin cancer	6.88e-05	0.00117	CcSEcCtD
Thiotepa—Chills—Temozolomide—skin cancer	6.85e-05	0.00117	CcSEcCtD
Thiotepa—Dehydration—Docetaxel—skin cancer	6.83e-05	0.00116	CcSEcCtD
Thiotepa—Anaemia—Dactinomycin—skin cancer	6.79e-05	0.00116	CcSEcCtD
Thiotepa—Vomiting—Vemurafenib—skin cancer	6.75e-05	0.00115	CcSEcCtD
Thiotepa—Alopecia—Temozolomide—skin cancer	6.75e-05	0.00115	CcSEcCtD
Thiotepa—Myalgia—Bleomycin—skin cancer	6.71e-05	0.00114	CcSEcCtD
Thiotepa—Rash—Vemurafenib—skin cancer	6.69e-05	0.00114	CcSEcCtD
Thiotepa—Mental disorder—Temozolomide—skin cancer	6.69e-05	0.00114	CcSEcCtD
Thiotepa—Dermatitis—Vemurafenib—skin cancer	6.69e-05	0.00114	CcSEcCtD
Thiotepa—Hypersensitivity—Imiquimod—skin cancer	6.67e-05	0.00113	CcSEcCtD
Thiotepa—Headache—Vemurafenib—skin cancer	6.65e-05	0.00113	CcSEcCtD
Thiotepa—Malnutrition—Temozolomide—skin cancer	6.65e-05	0.00113	CcSEcCtD
Thiotepa—Erythema—Temozolomide—skin cancer	6.65e-05	0.00113	CcSEcCtD
Thiotepa—Aspartate aminotransferase increased—Docetaxel—skin cancer	6.61e-05	0.00112	CcSEcCtD
Thiotepa—Leukopenia—Dactinomycin—skin cancer	6.58e-05	0.00112	CcSEcCtD
Thiotepa—Asthenia—Imiquimod—skin cancer	6.49e-05	0.0011	CcSEcCtD
Thiotepa—Confusional state—Bleomycin—skin cancer	6.48e-05	0.0011	CcSEcCtD
Thiotepa—Alanine aminotransferase increased—Docetaxel—skin cancer	6.47e-05	0.0011	CcSEcCtD
Thiotepa—Back pain—Temozolomide—skin cancer	6.43e-05	0.00109	CcSEcCtD
Thiotepa—Pruritus—Imiquimod—skin cancer	6.4e-05	0.00109	CcSEcCtD
Thiotepa—Infection—Bleomycin—skin cancer	6.39e-05	0.00109	CcSEcCtD
Thiotepa—Nausea—Vemurafenib—skin cancer	6.3e-05	0.00107	CcSEcCtD
Thiotepa—Thrombocytopenia—Bleomycin—skin cancer	6.3e-05	0.00107	CcSEcCtD
Thiotepa—Arrhythmia—Fluorouracil—skin cancer	6.28e-05	0.00107	CcSEcCtD
Thiotepa—Vision blurred—Temozolomide—skin cancer	6.26e-05	0.00107	CcSEcCtD
Thiotepa—Myalgia—Dactinomycin—skin cancer	6.26e-05	0.00106	CcSEcCtD
Thiotepa—Alopecia—Fluorouracil—skin cancer	6.22e-05	0.00106	CcSEcCtD
Thiotepa—Diarrhoea—Imiquimod—skin cancer	6.19e-05	0.00105	CcSEcCtD
Thiotepa—Anaemia—Temozolomide—skin cancer	6.14e-05	0.00104	CcSEcCtD
Thiotepa—Anorexia—Bleomycin—skin cancer	6.13e-05	0.00104	CcSEcCtD
Thiotepa—Erythema—Fluorouracil—skin cancer	6.12e-05	0.00104	CcSEcCtD
Thiotepa—Agitation—Temozolomide—skin cancer	6.11e-05	0.00104	CcSEcCtD
Thiotepa—Pancytopenia—Docetaxel—skin cancer	6.02e-05	0.00102	CcSEcCtD
Thiotepa—Dizziness—Imiquimod—skin cancer	5.99e-05	0.00102	CcSEcCtD
Thiotepa—Infection—Dactinomycin—skin cancer	5.96e-05	0.00101	CcSEcCtD
Thiotepa—Leukopenia—Temozolomide—skin cancer	5.95e-05	0.00101	CcSEcCtD
Thiotepa—Thrombocytopenia—Dactinomycin—skin cancer	5.87e-05	0.000999	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Bleomycin—skin cancer	5.86e-05	0.000996	CcSEcCtD
Thiotepa—Cough—Temozolomide—skin cancer	5.8e-05	0.000986	CcSEcCtD
Thiotepa—Paraesthesia—Bleomycin—skin cancer	5.77e-05	0.000982	CcSEcCtD
Thiotepa—Weight increased—Docetaxel—skin cancer	5.77e-05	0.000982	CcSEcCtD
Thiotepa—Vision blurred—Fluorouracil—skin cancer	5.77e-05	0.000981	CcSEcCtD
Thiotepa—Convulsion—Temozolomide—skin cancer	5.76e-05	0.000979	CcSEcCtD
Thiotepa—Vomiting—Imiquimod—skin cancer	5.76e-05	0.000979	CcSEcCtD
Thiotepa—Hypertension—Temozolomide—skin cancer	5.74e-05	0.000976	CcSEcCtD
Thiotepa—Anorexia—Dactinomycin—skin cancer	5.72e-05	0.000972	CcSEcCtD
Thiotepa—Rash—Imiquimod—skin cancer	5.71e-05	0.000971	CcSEcCtD
Thiotepa—Dermatitis—Imiquimod—skin cancer	5.7e-05	0.00097	CcSEcCtD
Thiotepa—Pneumonia—Docetaxel—skin cancer	5.69e-05	0.000967	CcSEcCtD
Thiotepa—Headache—Imiquimod—skin cancer	5.67e-05	0.000964	CcSEcCtD
Thiotepa—Anaemia—Fluorouracil—skin cancer	5.66e-05	0.000963	CcSEcCtD
Thiotepa—Arthralgia—Temozolomide—skin cancer	5.66e-05	0.000962	CcSEcCtD
Thiotepa—Myalgia—Temozolomide—skin cancer	5.66e-05	0.000962	CcSEcCtD
Thiotepa—Infestation NOS—Docetaxel—skin cancer	5.66e-05	0.000962	CcSEcCtD
Thiotepa—Infestation—Docetaxel—skin cancer	5.66e-05	0.000962	CcSEcCtD
Thiotepa—Anxiety—Temozolomide—skin cancer	5.64e-05	0.000959	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	5.62e-05	0.000956	CcSEcCtD
Thiotepa—Decreased appetite—Bleomycin—skin cancer	5.59e-05	0.000951	CcSEcCtD
Thiotepa—Renal failure—Docetaxel—skin cancer	5.56e-05	0.000945	CcSEcCtD
Thiotepa—Jaundice—Docetaxel—skin cancer	5.51e-05	0.000938	CcSEcCtD
Thiotepa—Stomatitis—Docetaxel—skin cancer	5.51e-05	0.000938	CcSEcCtD
Thiotepa—Pain—Bleomycin—skin cancer	5.5e-05	0.000935	CcSEcCtD
Thiotepa—Conjunctivitis—Docetaxel—skin cancer	5.5e-05	0.000935	CcSEcCtD
Thiotepa—Leukopenia—Fluorouracil—skin cancer	5.48e-05	0.000932	CcSEcCtD
Thiotepa—Confusional state—Temozolomide—skin cancer	5.47e-05	0.00093	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Dactinomycin—skin cancer	5.46e-05	0.000929	CcSEcCtD
Thiotepa—Infection—Temozolomide—skin cancer	5.39e-05	0.000916	CcSEcCtD
Thiotepa—Nausea—Imiquimod—skin cancer	5.38e-05	0.000914	CcSEcCtD
Thiotepa—Hepatobiliary disease—Docetaxel—skin cancer	5.35e-05	0.00091	CcSEcCtD
Thiotepa—Epistaxis—Docetaxel—skin cancer	5.33e-05	0.000907	CcSEcCtD
Thiotepa—Nervous system disorder—Temozolomide—skin cancer	5.32e-05	0.000905	CcSEcCtD
Thiotepa—Thrombocytopenia—Temozolomide—skin cancer	5.31e-05	0.000903	CcSEcCtD
Thiotepa—Convulsion—Fluorouracil—skin cancer	5.31e-05	0.000902	CcSEcCtD
Thiotepa—Feeling abnormal—Bleomycin—skin cancer	5.3e-05	0.000901	CcSEcCtD
Thiotepa—Agranulocytosis—Docetaxel—skin cancer	5.28e-05	0.000898	CcSEcCtD
Thiotepa—Skin disorder—Temozolomide—skin cancer	5.27e-05	0.000896	CcSEcCtD
Thiotepa—Myalgia—Fluorouracil—skin cancer	5.21e-05	0.000887	CcSEcCtD
Thiotepa—Decreased appetite—Dactinomycin—skin cancer	5.21e-05	0.000887	CcSEcCtD
Thiotepa—Fatigue—Dactinomycin—skin cancer	5.17e-05	0.000879	CcSEcCtD
Thiotepa—Anorexia—Temozolomide—skin cancer	5.17e-05	0.000879	CcSEcCtD
Thiotepa—Pain—Dactinomycin—skin cancer	5.13e-05	0.000872	CcSEcCtD
Thiotepa—Urticaria—Bleomycin—skin cancer	5.11e-05	0.000869	CcSEcCtD
Thiotepa—Haemoglobin—Docetaxel—skin cancer	5.1e-05	0.000868	CcSEcCtD
Thiotepa—Body temperature increased—Bleomycin—skin cancer	5.08e-05	0.000864	CcSEcCtD
Thiotepa—Haemorrhage—Docetaxel—skin cancer	5.08e-05	0.000863	CcSEcCtD
Thiotepa—Confusional state—Fluorouracil—skin cancer	5.04e-05	0.000857	CcSEcCtD
Thiotepa—Urinary tract disorder—Docetaxel—skin cancer	5.01e-05	0.000853	CcSEcCtD
Thiotepa—Connective tissue disorder—Docetaxel—skin cancer	4.99e-05	0.000848	CcSEcCtD
Thiotepa—Urethral disorder—Docetaxel—skin cancer	4.98e-05	0.000846	CcSEcCtD
Thiotepa—Infection—Fluorouracil—skin cancer	4.97e-05	0.000844	CcSEcCtD
Thiotepa—Feeling abnormal—Dactinomycin—skin cancer	4.94e-05	0.00084	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Temozolomide—skin cancer	4.94e-05	0.00084	CcSEcCtD
Thiotepa—Gastrointestinal pain—Dactinomycin—skin cancer	4.9e-05	0.000834	CcSEcCtD
Thiotepa—Nervous system disorder—Fluorouracil—skin cancer	4.9e-05	0.000834	CcSEcCtD
Thiotepa—Thrombocytopenia—Fluorouracil—skin cancer	4.89e-05	0.000832	CcSEcCtD
Thiotepa—Tachycardia—Fluorouracil—skin cancer	4.88e-05	0.00083	CcSEcCtD
Thiotepa—Paraesthesia—Temozolomide—skin cancer	4.87e-05	0.000828	CcSEcCtD
Thiotepa—Somnolence—Temozolomide—skin cancer	4.82e-05	0.00082	CcSEcCtD
Thiotepa—Dyspepsia—Temozolomide—skin cancer	4.77e-05	0.000812	CcSEcCtD
Thiotepa—Anorexia—Fluorouracil—skin cancer	4.76e-05	0.00081	CcSEcCtD
Thiotepa—Eye disorder—Docetaxel—skin cancer	4.74e-05	0.000807	CcSEcCtD
Thiotepa—Body temperature increased—Dactinomycin—skin cancer	4.74e-05	0.000806	CcSEcCtD
Thiotepa—Abdominal pain—Dactinomycin—skin cancer	4.74e-05	0.000806	CcSEcCtD
Thiotepa—Hypersensitivity—Bleomycin—skin cancer	4.74e-05	0.000806	CcSEcCtD
Thiotepa—Decreased appetite—Temozolomide—skin cancer	4.72e-05	0.000802	CcSEcCtD
Thiotepa—Cardiac disorder—Docetaxel—skin cancer	4.71e-05	0.000801	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Temozolomide—skin cancer	4.68e-05	0.000796	CcSEcCtD
Thiotepa—Fatigue—Temozolomide—skin cancer	4.68e-05	0.000795	CcSEcCtD
Thiotepa—Pain—Temozolomide—skin cancer	4.64e-05	0.000789	CcSEcCtD
Thiotepa—Constipation—Temozolomide—skin cancer	4.64e-05	0.000789	CcSEcCtD
Thiotepa—Asthenia—Bleomycin—skin cancer	4.61e-05	0.000785	CcSEcCtD
Thiotepa—Angiopathy—Docetaxel—skin cancer	4.61e-05	0.000783	CcSEcCtD
Thiotepa—Immune system disorder—Docetaxel—skin cancer	4.59e-05	0.00078	CcSEcCtD
Thiotepa—Mediastinal disorder—Docetaxel—skin cancer	4.58e-05	0.000778	CcSEcCtD
Thiotepa—Chills—Docetaxel—skin cancer	4.56e-05	0.000775	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Fluorouracil—skin cancer	4.55e-05	0.000774	CcSEcCtD
Thiotepa—Pruritus—Bleomycin—skin cancer	4.55e-05	0.000774	CcSEcCtD
Thiotepa—Arrhythmia—Docetaxel—skin cancer	4.54e-05	0.000771	CcSEcCtD
Thiotepa—Paraesthesia—Fluorouracil—skin cancer	4.49e-05	0.000763	CcSEcCtD
Thiotepa—Alopecia—Docetaxel—skin cancer	4.49e-05	0.000763	CcSEcCtD
Thiotepa—Feeling abnormal—Temozolomide—skin cancer	4.47e-05	0.00076	CcSEcCtD
Thiotepa—Mental disorder—Docetaxel—skin cancer	4.45e-05	0.000756	CcSEcCtD
Thiotepa—Somnolence—Fluorouracil—skin cancer	4.44e-05	0.000756	CcSEcCtD
Thiotepa—Gastrointestinal pain—Temozolomide—skin cancer	4.44e-05	0.000754	CcSEcCtD
Thiotepa—Erythema—Docetaxel—skin cancer	4.42e-05	0.000752	CcSEcCtD
Thiotepa—Malnutrition—Docetaxel—skin cancer	4.42e-05	0.000752	CcSEcCtD
Thiotepa—Hypersensitivity—Dactinomycin—skin cancer	4.42e-05	0.000751	CcSEcCtD
Thiotepa—Dyspepsia—Fluorouracil—skin cancer	4.4e-05	0.000748	CcSEcCtD
Thiotepa—Decreased appetite—Fluorouracil—skin cancer	4.34e-05	0.000739	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Fluorouracil—skin cancer	4.31e-05	0.000734	CcSEcCtD
Thiotepa—Urticaria—Temozolomide—skin cancer	4.31e-05	0.000733	CcSEcCtD
Thiotepa—Asthenia—Dactinomycin—skin cancer	4.3e-05	0.000732	CcSEcCtD
Thiotepa—Body temperature increased—Temozolomide—skin cancer	4.29e-05	0.000729	CcSEcCtD
Thiotepa—Abdominal pain—Temozolomide—skin cancer	4.29e-05	0.000729	CcSEcCtD
Thiotepa—Back pain—Docetaxel—skin cancer	4.28e-05	0.000727	CcSEcCtD
Thiotepa—Pain—Fluorouracil—skin cancer	4.27e-05	0.000727	CcSEcCtD
Thiotepa—Feeling abnormal—Fluorouracil—skin cancer	4.12e-05	0.0007	CcSEcCtD
Thiotepa—Diarrhoea—Dactinomycin—skin cancer	4.1e-05	0.000698	CcSEcCtD
Thiotepa—Vomiting—Bleomycin—skin cancer	4.09e-05	0.000695	CcSEcCtD
Thiotepa—Anaemia—Docetaxel—skin cancer	4.09e-05	0.000695	CcSEcCtD
Thiotepa—Rash—Bleomycin—skin cancer	4.05e-05	0.00069	CcSEcCtD
Thiotepa—Dermatitis—Bleomycin—skin cancer	4.05e-05	0.000689	CcSEcCtD
Thiotepa—Hypersensitivity—Temozolomide—skin cancer	4e-05	0.00068	CcSEcCtD
Thiotepa—Urticaria—Fluorouracil—skin cancer	3.97e-05	0.000675	CcSEcCtD
Thiotepa—Leukopenia—Docetaxel—skin cancer	3.96e-05	0.000673	CcSEcCtD
Thiotepa—Body temperature increased—Fluorouracil—skin cancer	3.95e-05	0.000672	CcSEcCtD
Thiotepa—Asthenia—Temozolomide—skin cancer	3.89e-05	0.000662	CcSEcCtD
Thiotepa—Cough—Docetaxel—skin cancer	3.86e-05	0.000656	CcSEcCtD
Thiotepa—Pruritus—Temozolomide—skin cancer	3.84e-05	0.000653	CcSEcCtD
Thiotepa—Convulsion—Docetaxel—skin cancer	3.83e-05	0.000651	CcSEcCtD
Thiotepa—Nausea—Bleomycin—skin cancer	3.82e-05	0.00065	CcSEcCtD
Thiotepa—Hypertension—Docetaxel—skin cancer	3.82e-05	0.000649	CcSEcCtD
Thiotepa—Vomiting—Dactinomycin—skin cancer	3.81e-05	0.000648	CcSEcCtD
Thiotepa—Rash—Dactinomycin—skin cancer	3.78e-05	0.000643	CcSEcCtD
Thiotepa—Myalgia—Docetaxel—skin cancer	3.76e-05	0.00064	CcSEcCtD
Thiotepa—Arthralgia—Docetaxel—skin cancer	3.76e-05	0.00064	CcSEcCtD
Thiotepa—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	3.74e-05	0.000636	CcSEcCtD
Thiotepa—Diarrhoea—Temozolomide—skin cancer	3.71e-05	0.000631	CcSEcCtD
Thiotepa—Hypersensitivity—Fluorouracil—skin cancer	3.68e-05	0.000626	CcSEcCtD
Thiotepa—Confusional state—Docetaxel—skin cancer	3.64e-05	0.000619	CcSEcCtD
Thiotepa—Dizziness—Temozolomide—skin cancer	3.59e-05	0.00061	CcSEcCtD
Thiotepa—Infection—Docetaxel—skin cancer	3.58e-05	0.000609	CcSEcCtD
Thiotepa—Nausea—Dactinomycin—skin cancer	3.56e-05	0.000606	CcSEcCtD
Thiotepa—Nervous system disorder—Docetaxel—skin cancer	3.54e-05	0.000602	CcSEcCtD
Thiotepa—Pruritus—Fluorouracil—skin cancer	3.54e-05	0.000601	CcSEcCtD
Thiotepa—Thrombocytopenia—Docetaxel—skin cancer	3.53e-05	0.000601	CcSEcCtD
Thiotepa—Tachycardia—Docetaxel—skin cancer	3.52e-05	0.000599	CcSEcCtD
Thiotepa—Skin disorder—Docetaxel—skin cancer	3.5e-05	0.000596	CcSEcCtD
Thiotepa—Vomiting—Temozolomide—skin cancer	3.45e-05	0.000587	CcSEcCtD
Thiotepa—Anorexia—Docetaxel—skin cancer	3.44e-05	0.000585	CcSEcCtD
Thiotepa—Rash—Temozolomide—skin cancer	3.42e-05	0.000582	CcSEcCtD
Thiotepa—Diarrhoea—Fluorouracil—skin cancer	3.42e-05	0.000582	CcSEcCtD
Thiotepa—Dermatitis—Temozolomide—skin cancer	3.42e-05	0.000581	CcSEcCtD
Thiotepa—Headache—Temozolomide—skin cancer	3.4e-05	0.000578	CcSEcCtD
Thiotepa—Dizziness—Fluorouracil—skin cancer	3.3e-05	0.000562	CcSEcCtD
Thiotepa—Musculoskeletal discomfort—Docetaxel—skin cancer	3.29e-05	0.000559	CcSEcCtD
Thiotepa—Paraesthesia—Docetaxel—skin cancer	3.24e-05	0.000551	CcSEcCtD
Thiotepa—Nausea—Temozolomide—skin cancer	3.22e-05	0.000548	CcSEcCtD
Thiotepa—Somnolence—Docetaxel—skin cancer	3.21e-05	0.000545	CcSEcCtD
Thiotepa—Vomiting—Fluorouracil—skin cancer	3.18e-05	0.00054	CcSEcCtD
Thiotepa—Dyspepsia—Docetaxel—skin cancer	3.18e-05	0.00054	CcSEcCtD
Thiotepa—Rash—Fluorouracil—skin cancer	3.15e-05	0.000536	CcSEcCtD
Thiotepa—Dermatitis—Fluorouracil—skin cancer	3.15e-05	0.000535	CcSEcCtD
Thiotepa—Decreased appetite—Docetaxel—skin cancer	3.14e-05	0.000533	CcSEcCtD
Thiotepa—Headache—Fluorouracil—skin cancer	3.13e-05	0.000532	CcSEcCtD
Thiotepa—Gastrointestinal disorder—Docetaxel—skin cancer	3.11e-05	0.00053	CcSEcCtD
Thiotepa—Fatigue—Docetaxel—skin cancer	3.11e-05	0.000529	CcSEcCtD
Thiotepa—Pain—Docetaxel—skin cancer	3.08e-05	0.000525	CcSEcCtD
Thiotepa—Constipation—Docetaxel—skin cancer	3.08e-05	0.000525	CcSEcCtD
Thiotepa—Feeling abnormal—Docetaxel—skin cancer	2.97e-05	0.000506	CcSEcCtD
Thiotepa—Nausea—Fluorouracil—skin cancer	2.97e-05	0.000505	CcSEcCtD
Thiotepa—Gastrointestinal pain—Docetaxel—skin cancer	2.95e-05	0.000502	CcSEcCtD
Thiotepa—Abdominal pain—Docetaxel—skin cancer	2.85e-05	0.000485	CcSEcCtD
Thiotepa—Body temperature increased—Docetaxel—skin cancer	2.85e-05	0.000485	CcSEcCtD
Thiotepa—Hypersensitivity—Docetaxel—skin cancer	2.66e-05	0.000452	CcSEcCtD
Thiotepa—Asthenia—Docetaxel—skin cancer	2.59e-05	0.00044	CcSEcCtD
Thiotepa—Pruritus—Docetaxel—skin cancer	2.55e-05	0.000434	CcSEcCtD
Thiotepa—Diarrhoea—Docetaxel—skin cancer	2.47e-05	0.00042	CcSEcCtD
Thiotepa—Dizziness—Docetaxel—skin cancer	2.39e-05	0.000406	CcSEcCtD
Thiotepa—Vomiting—Docetaxel—skin cancer	2.29e-05	0.00039	CcSEcCtD
Thiotepa—Rash—Docetaxel—skin cancer	2.27e-05	0.000387	CcSEcCtD
Thiotepa—Dermatitis—Docetaxel—skin cancer	2.27e-05	0.000386	CcSEcCtD
Thiotepa—Headache—Docetaxel—skin cancer	2.26e-05	0.000384	CcSEcCtD
Thiotepa—Nausea—Docetaxel—skin cancer	2.14e-05	0.000364	CcSEcCtD
